Fig. 1 · Structure
Documents & Downloads
ABT-702
Adenosine Kinase Inhibitor
ABT-702 is a selective adenosine kinase inhibitor with an IC50 of 1.7 nM, demonstrating over 1300-fold selectivity for adenosine kinase compared to other biological targets such as cyclooxygenases-1 and -2. This compound effectively increases free adenosine levels, thereby attenuating inflammation associated with diabetic retinopathy. In vivo studies reveal its analgesic and anti-inflammatory effects, supporting its use in research related to diabetic retinopathy and other inflammatory conditions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 214697-26-4 |
| Applications | Adenosine Kinase Inhibitor |
| Formula | C22H19BrN6O |
| Molecular Weight | 463.33 |
| SMILES | BrC1=CC=CC(C2=C3C(N)=NC=NC3=NC(C4=CC=C(N5CCOCC5)N=C4)=C2)=C1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.